Abstract:The dramatic increase in the use of nanoparticles (NP) in industry and research has raised questions about the potential toxicity of such materials. Unfortunately, not enough is known about how the novel, technologically-attractive properties of NPs correlate with the interactions that may take place at the nano/bio interface. The academic, industrial, and regulatory communities are actively seeking answers to the growing concerns on the impact of nanotechnology on humans. In this Account we adopt quantum dots (QDs) as an illustrative example of the difficulties associated with the development of a rational science-based approach to nanotoxicology. The optical properties of QDs are far superior to those of organic dyes in terms of emission and absorption bandwidths, quantum yield, and resistance to photobleaching. Moreover, QDs may be decorated with targeting moieties or drugs and, therefore, are candidates for site-specific medical imaging and for drug delivery, for example in cancer treatment. Earlier this year researchers demonstrated that QD-based imaging using monkeys caused no adverse effects although QDs accumulated in lymph nodes, bone marrow, liver, and spleen for up to 3 months after injection. Such persistence of QDs in live animals does, however, raise concerns about the safety of using QDs both in the laboratory and in the clinic. Researchers anticipate that QDs will be increasingly used not only in clinical applications but also in various manufactured products. For example, QD-solar cells have emerged as viable contenders to complement or replace dye-sensitized solar cells; CdTe/CdS thin film cells have already captured approximately 10 percent of the global market, and in addition, QDs can serve as components of sensors and as emitting materials in LEDs. Given the clear indications that QDs will inevitably become components of a wide range of manufactured and consumer products, researchers and policy makers need to understand the possible health risks associated with exposure to QDs. In this Account, we initially review the known mechanisms by which QDs can damage cells, including oxidative stress elicited by reactive oxygen species (ROS). We discuss lesser-known impairments induced in cells by nanomolar to picomolar concentrations of QDs, which imply that cadmium-containing QDs can exert genotoxic, epigenetic, and metalloestrogenic effects. These observations strongly suggest that minute concentrations of QDs could be sufficient to cause long lasting, even transgenerational, effects. We also consider various modes by which humans could be exposed to QDs in their work or through the environment. Although considerable advances have been made in enhancing the stability and overall quality of QDs, over time they can partially degrade in the environment or in biological systems, and eventually cause small, but cumulative undesirable effects. A combination of toxicological, genetic, epigenetic and imaging approaches is required to create comprehensive guidelines for evaluating the nanotoxicity of nanomaterials, including QDs. Prior to biological investigations with these materials, an indispensible step must be the full characterization of NPs by complementary techniques. Specifically, the concentration, size, charge, and ligand stability of NPs in biological media must be known if we are to understand fully how the properties of nanoparticles and of their biological environment contribute to cytotoxicity.

Comprehensive evaluation of the nephrotoxicity of carbon quantum dots: Effects of the surface charge

Hepatotoxicity evaluations of different surface charged carbon quantum dots in vivo and in vitro

Carbon Dots of Different Composition and Surface Functionalization: Cytotoxicity Issues Relevant to Fluorescence Cell Imaging

Research progress in toxicity of carbon quantum dots

An in vitro study of vascular endothelial toxicity of CdTe quantum dots.

Quantum dot-related genotoxicity perturbation can be attenuated by PEG encapsulation.

Acute Toxicity and Prothrombotic Effects of Quantum Dots: Impact of Surface Charge

Toxicity Assessment Of Phospholipid Micelle-Encapsulated Cadmium-Based Quantum Dots Using Kunming Mice

Systematic Toxicity Evaluations of High-Performance Carbon "Quantum" Dots

The Cytotoxicity of Cadmium-Based Quantum Dots

Toxic or Not Toxic, That Is the Carbon Quantum Dot’s Question: A Comprehensive Evaluation with Zebrafish Embryo, Eleutheroembryo, and Adult Models

Quantum dot cytotoxicity and ways to reduce it

The effects of composition and surface chemistry on the toxicity of quantum dots.

New Insights into the Cellular Toxicity of Carbon Quantum Dots to Escherichia coli

The Effect of Surface Charge on the Cytotoxicity and Uptake of Carbon Quantum Dots in Human Umbilical Cord Derived Mesenchymal Stem Cells.

Cellular uptake, intracellular behavior, and acute/sub-acute cytotoxicity of a PEG-modified quantum dot with promising in-vivo biomedical applications

Cytotoxicity Evaluations Of Fluorescent Carbon Nanoparticles

Parallel Comparative Studies on Toxicity of Quantum Dots Synthesized and Surface Engineered with Different Methods in Vitro and in Vivo

The Cytotoxicity of Cadmium Based, Aqueous Phase - Synthesized, Quantum Dots and Its Modulation by Surface Coating

A review of pulmonary toxicity of different types of quantum dots in environmental and biological systems

Toxicity of quantum dots on target organs and immune system